Effectiveness of laryngeal reinnervation compared to medialization thyroplasty in the treatment of unilateral vocal fold paralysis: A systematic review and network meta-analysis.

IF 1.4 Q2 Medicine
World Journal of OtorhinolaryngologyHead and Neck Surgery Pub Date : 2024-09-11 eCollection Date: 2025-09-01 DOI:10.1002/wjo2.214
Muhnnad A AlGhamdi, Lama Nasser Alghamdi, Mohamed Khalid AlQazenli, Dhay Saleh Alrashid, Zainab Bakhsh
{"title":"Effectiveness of laryngeal reinnervation compared to medialization thyroplasty in the treatment of unilateral vocal fold paralysis: A systematic review and network meta-analysis.","authors":"Muhnnad A AlGhamdi, Lama Nasser Alghamdi, Mohamed Khalid AlQazenli, Dhay Saleh Alrashid, Zainab Bakhsh","doi":"10.1002/wjo2.214","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Unilateral vocal fold paralysis (ULVP) is characterized by the complete immobility of a single vocal fold which can cause significant health challenges, including voice impairment, difficulty swallowing, and a high risk of aspiration due to glottic incompetency. The aim of this study is to systematically review the effectiveness of laryngeal reinnervation (LR) and medialization thyroplasty (MT) in the treatment of ULVP.</p><p><strong>Materials and methods: </strong>Medline, PubMed, Cochrane Library, OVID, Scopus, Springer Nature Journals, ScienceDirect, and Directory of Open Access Journals databases were searched. Restriction to non-English studies were applied. Studies were excluded if subjects had previous treatment for ULVP, if they had co-existing neuromuscular disease affecting the larynx, and if they had significant non-laryngeal speech abnormalities.</p><p><strong>Results: </strong>Fifteen articles were reviewed, all conducted between 2003 and 2023. Among the 864 participants included, 48 underwent LR, 348 underwent MT, and the remaining 432 were in the comparison group, which involved injection laryngoplasty (IL), voice therapy (VT), placebo, and medialization with arytenoid adduction. Meta-analyses compared LR to MT and MT to alternative treatments, revealing a preference for MT. The comparison between LR and MT in the network meta-analysis yielded a mean difference of 0.33 (95% CI: -11.79, 12.6) favoring the MT group, ranking using SUCRA values highlighted that MT is the best treatment modality followed by LR.</p><p><strong>Discussion: </strong>The results of the network meta-analysis and the subgroup meta-analysis showed that MT is better than alternative treatments that were included in this study. Moreover, management modalities should be individualized to each patient as many factors are important and may affect the final outcomes.</p><p><strong>Conclusions: </strong>While the network meta-analysis indicates that MT may be more effective than alternative treatments for managing ULVP, the results should be interpreted with caution due to potential confounding factors. One notable limitation is the small sample size in the LR group. Despite these limitations, the findings contribute to the existing literature and can help guide future research on optimal interventions for the treatment of ULVP.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"11 3","pages":"449-461"},"PeriodicalIF":1.4000,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12418357/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of OtorhinolaryngologyHead and Neck Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/wjo2.214","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Unilateral vocal fold paralysis (ULVP) is characterized by the complete immobility of a single vocal fold which can cause significant health challenges, including voice impairment, difficulty swallowing, and a high risk of aspiration due to glottic incompetency. The aim of this study is to systematically review the effectiveness of laryngeal reinnervation (LR) and medialization thyroplasty (MT) in the treatment of ULVP.

Materials and methods: Medline, PubMed, Cochrane Library, OVID, Scopus, Springer Nature Journals, ScienceDirect, and Directory of Open Access Journals databases were searched. Restriction to non-English studies were applied. Studies were excluded if subjects had previous treatment for ULVP, if they had co-existing neuromuscular disease affecting the larynx, and if they had significant non-laryngeal speech abnormalities.

Results: Fifteen articles were reviewed, all conducted between 2003 and 2023. Among the 864 participants included, 48 underwent LR, 348 underwent MT, and the remaining 432 were in the comparison group, which involved injection laryngoplasty (IL), voice therapy (VT), placebo, and medialization with arytenoid adduction. Meta-analyses compared LR to MT and MT to alternative treatments, revealing a preference for MT. The comparison between LR and MT in the network meta-analysis yielded a mean difference of 0.33 (95% CI: -11.79, 12.6) favoring the MT group, ranking using SUCRA values highlighted that MT is the best treatment modality followed by LR.

Discussion: The results of the network meta-analysis and the subgroup meta-analysis showed that MT is better than alternative treatments that were included in this study. Moreover, management modalities should be individualized to each patient as many factors are important and may affect the final outcomes.

Conclusions: While the network meta-analysis indicates that MT may be more effective than alternative treatments for managing ULVP, the results should be interpreted with caution due to potential confounding factors. One notable limitation is the small sample size in the LR group. Despite these limitations, the findings contribute to the existing literature and can help guide future research on optimal interventions for the treatment of ULVP.

Abstract Image

Abstract Image

Abstract Image

喉神经再支配与内侧化甲状腺成形术治疗单侧声带麻痹的疗效比较:系统回顾和网络荟萃分析。
单侧声带麻痹(ULVP)的特点是单侧声带完全不活动,可引起严重的健康问题,包括声音障碍、吞咽困难和声门功能不全导致的高吸入性风险。本研究的目的是系统地回顾喉再神经支配(LR)和中间化甲状腺成形术(MT)治疗ULVP的有效性。资料和方法:检索Medline、PubMed、Cochrane Library、OVID、Scopus、施普林格Nature Journals、ScienceDirect、Directory of Open Access Journals数据库。对非英语学习进行了限制。如果受试者之前接受过ULVP治疗,如果他们同时患有影响喉部的神经肌肉疾病,如果他们有明显的非喉部语言异常,则排除研究。结果:共纳入文献15篇,均为2003 - 2023年间的文献。在纳入的864名参与者中,48人接受了LR, 348人接受了MT,其余432人在对照组,包括注射喉部成形术(IL),声音治疗(VT),安慰剂和用类喉关节内收进行媒质化。荟萃分析将LR与MT和MT与替代治疗进行了比较,显示出对MT的偏好。网络荟萃分析中LR和MT的比较结果显示,MT组的平均差异为0.33 (95% CI: -11.79, 12.6),使用SUCRA值进行排名,突出了MT是最佳治疗方式,其次是LR。讨论:网络荟萃分析和亚组荟萃分析结果显示,MT优于本研究纳入的替代治疗。此外,由于许多因素都很重要,可能会影响最终结果,因此治疗方式应因人而异。结论:虽然网络荟萃分析表明MT可能比其他治疗方法更有效地治疗ULVP,但由于潜在的混杂因素,结果应谨慎解释。一个值得注意的限制是LR组的样本量小。尽管存在这些局限性,但这些发现有助于现有文献,并有助于指导未来对ULVP治疗的最佳干预措施的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
283
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信